MAESTRONASH

Entera Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference - Entera Bio (NASDAQ:ENTX)

Madrigal Pharmaceuticals Announces Publication of the Phase 3 MAESTRO-NASH Trial of Resmetirom in the New England Journal of Medicine – Madrigal Pharmaceuticals (NASDAQ:MDGL)

top